Noninvasive detection of brain gliomas using plasma cell‐free DNA 5‐hydroxymethylcytosine sequencing
- 28 December 2022
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 152 (8) , 1707-1718
Abstract
Liquid biopsy techniques based on deep sequencing of plasma cell-free DNA (cfDNA) could detect the low-frequency somatic mutations and provide an accurate diagnosis for many cancers. However, for brain gliomas, reliable performance of these techniques currently requires obtaining cfDNA from patients' cerebral spinal fluid, which is cumbersome and risky. Here we report a liquid biopsy method based on sequencing of plasma cfDNA fragments carrying 5-hydroxymethylcytosine (5hmC) using selective chemical labeling (hMe-Seal). We first constructed a dataset including 180 glioma patients and 229 non-glioma controls. We found marked concordance between cfDNA hydroxymethylome and the aberrant transcriptome of the underlying gliomas. Functional analysis also revealed overrepresentation of the differentially hydroxymethylated genes (DhmGs) in oncogenic and neural pathways. After splitting our dataset into training and test cohort, we showed that a penalized logistic model constructed with training set DhmGs could distinguish glioma patients from healthy controls in both our test set (AUC = 0.962) and an independent dataset (AUC = 0.930) consisting of 111 gliomas and 111 controls. Additionally, the DhmGs between gliomas with mutant and wild-type isocitrate dehydrogenase (IDH) could be used to train a cfDNA predictor of the IDH mutation status of the underlying tumor (AUC = 0.816), and patients with predicted IDH mutant gliomas had significantly better outcome (P = .01). These results indicate that our plasma cfDNA 5hmC sequencing method could obtain glioma-specific signals, which may be used to noninvasively detect these patients and predict the aggressiveness of their tumors.Keywords
Funding Information
- Science and Technology Department of Sichuan Province (2017SZ0006, 2020YFS0051)
- National Natural Science Foundation of China (81802096)
- Sichuan University (19HXCX009, 20HXBH035)
This publication has 40 references indexed in Scilit:
- Detection of IDH1 mutation in the plasma of patients with gliomaNeurology, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiationNature, 2011
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Tissue Distribution of 5-Hydroxymethylcytosine and Search for Active Demethylation IntermediatesPLOS ONE, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the BrainScience, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- High-grade and low-grade gliomas: differentiation by using perfusion MR imagingClinical Radiology, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005